Restless Legs Syndrome Trial, Recruiting (NCT06481176)

Restless Legs Syndrome Trial, Recruiting NCT06481176 Sponsor: Stanford University Condition: Restless Legs Syndrome

Printed from Voxsanity (voxsanity.com.au) — NCT06481176 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Restless Legs Syndrome

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are 18 years of age or older
You have been diagnosed with Restless Legs Syndrome (RLS)
Your RLS symptoms are rated as moderate to severe (based on a standard scoring system used by doctors)
You are not currently receiving any treatment for your RLS
You have not been doing regular physical activity (at least 30 minutes a day) on more than 2 days per week for the past six months
You are able to walk on your own without using a cane, walker, or wheelchair
You are willing to complete all measurements and participate in the full exercise program

Who may not be able to join:

You have a condition that could cause similar symptoms to RLS or trigger RLS as a side effect — for example, iron deficiency anemia, nerve pain in the back, swelling in the legs, nerve damage in the hands or feet, or diabetes
You have been assessed as being at moderate or high risk when doing intense or maximum-effort exercise (confirm with trial site)

⚠️ Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Emmanuel Mignot, MD, PhD, Stanford University

Phone: (650) 725-6517

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06481176

Sponsor: Stanford University

Phase: Not Applicable

Status: Recruiting

Condition: Restless Legs Syndrome

Trial contact: (650) 725-6517

More information: https://clinicaltrials.gov/study/NCT06481176

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are 18 years of age or older
You have been diagnosed with Restless Legs Syndrome (RLS)
Your RLS symptoms are rated as moderate to severe (based on a standard scoring system used by doctors)
You are not currently receiving any treatment for your RLS
You have not been doing regular physical activity (at least 30 minutes a day) on more than 2 days per week for the past six months
You are able to walk on your own without using a cane, walker, or wheelchair
You are willing to complete all measurements and participate in the full exercise program

Who may not be able to join:

You have a condition that could cause similar symptoms to RLS or trigger RLS as a side effect — for example, iron deficiency anemia, nerve pain in the back, swelling in the legs, nerve damage in the hands or feet, or diabetes
You have been assessed as being at moderate or high risk when doing intense or maximum-effort exercise (confirm with trial site)

⚠️ Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Stanford University

Registry

ClinicalTrials.gov

Start date

21 October 2024

Est. completion

1 August 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Protein Expression Profile; Protein Expression Profile

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov